PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes. An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker.

PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization.

PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.

《Pharmacoeconomics》是一本由ADIS INT LTD出版商出版的专业医学期刊，该刊创刊于1992年，刊期Monthly，该刊已被国际权威数据库SCIE、SSCI、SCI收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：经济学 3区；卫生保健与服务 3区；卫生政策与服务 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖卫生保健与服务等领域，旨在及时、准确、全面地报道国内外卫生保健与服务工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为4.558，平均审稿速度较慢,6-12周。